It is becoming increasingly difficult to ignore the fact that genetic-based diseases are hard to predict and address. One of such disorders is an autism spectrum disorder, which is based on the mutation of genes. Usually, Y chromosomes inherited by males contain a mutated pattern which affects certain functions of brain. A common knowledge regarding an autism spectrum disorder suggests that gene mutation can be caused by three major factors: genetic predisposition, environmental impacts, and drastic age difference between the parents of a child with an ASD.
Since autism is presented with the entire spectrum of disorders, it is necessary to say that gene mutation usually affects other developmental and functional aspects of a child's organism. The ASD itself manifests in a strong absence of social reciprocity, tantrum behaviors, inability to communicate, hyperactivity, aggression, self-injury, and repetitive behaviors. The autism spectrum disorder is recognized as a life-long condition, but it is treatable and ASD individuals can adjust to living in the society and perform basic life functions. The ASD is often regarded as an alternative state of mind, but the most prominent and mainstream studies admit that it is a mental and social disability based on the mutation of genes. To be more specific, duplications, inversions, and deletions are the associated chromosomic disorders which are assumed to be the primary causes of the autism spectrum disorder. The disorder is usually recognized at prenatal or early stages of postnatal period, so that treatment can start in early childhood. Taking these points into account, the following paper provides an account of medical, financial, and family perspectives of addressing the autism spectrum disorder.
As a matter of fact, FDA has approved two basic medications to address autism spectrum disorder symptoms. The drugs such as risperidone and aripiprazole are antipsychotic and have been reported to demonstrate strong efficiency in regards to the reduction of tantrum behaviors, aggression, and self-injury (Lecavalier et al., 2014). Therefore, the successful adoption of these medications suggests that a more specific line of drugs for addressing ASD symptoms can be designed in the nearest future. That is why the closest objectives for drug adoption in that regard are anxiety, the absence of sleep, reciprocal disability, repetitive behaviors, and hyperactivity (Lecavalier et al., 2014). Anxiety is a common symptom among children with autism spectrum disorders, which is why a particular focus is placed on that aspect. Nonetheless, this issue has been not raged unabated yet owing to a number of reasons.
The matter is that anxiety among children with ASD does not differ from anxiety among healthy children (Lecavalier et al., 2014). Thus, FDA is quite concerned regarding the approval of the related drugs, as their adoption can be potentially based on narrow terms which are insufficient for making such a judgement., Since the current knowledge in the field is quite vague nowadays and the medications are limited to the two aforementioned drugs, a new safety test is obviously needed.
Speaking of the financial perspective of ASD treatment, it is relevant to note that money and grants play a pivotal role here. In spite of the fact that the Fight Autism Act has been enacted more than a decade ago and now it is commonly practiced, local communities still face numerous problems regarding the accessibility of related services and mental health assistance, with the social mobility of ASD children and their parents being limited (Al-Farsi et al., 2013). Otherwise, they have to experience considerable expenses on accommodation within the area of the nearest mental health center and a special education school. Grants are obviously important to the same extent, but common practice suggests that citizens usually do not rely on such a possibility. Families with ASD children are often forced to leave their well-paid jobs in order to sustain care for their mentally, behaviorally, and socially challenged children (Al-Farsi et al., 2013). Therefore, money plays a significant role in terms of ensuring sufficient well-being of such families (Al-Farsi et al., 2013). A capitalistic model of healthcare evidently works not in favor of these families as the absence of finance to provide an appropriate care to their children places them in a socio-economic jeopardy which is often hard to resolve even with a presence of grants and basic medical insurance policies.
In general, the involvement of family is increasingly important owing to multiple reasons. First of all, family (parental) involvement in treatment is critical for the autism spectrum disorder prognosis (Burell & Borrego, 2012). Family can serve a perfect function of caregivers and interventionists, and their active participation is the best way of approaching a child with autism spectrum disorder as his/her family knows best all the peculiarities and specific conditions related to the disorder (Burell & Borrego, 2012). That is why observation, behavior correction, and provision of basic care are the most fundamental advantages of parental involvement in addressing the ASD (Burell & Borrego, 2012). That can be justified with the fact that parents educate their children in many ways: domestic routines, behaving themselves, social interaction with elder people and with peers, etc. The same activities are applicable to children with the autism spectrum disorder as long as their complete social integration is one of the main objectives of treatment. Beyond a doubt, parents/families have to undergo certain training as well as their participation in education and interventions of a child with the ASD is quite natural (Burell & Borrego, 2012). Hence, the role of family/parental involvement in cases of autism spectrum disorder is paramount and should be not underestimated.
In conclusion, it is appropriate to make a general comment on the fact that the autism spectrum disorder is a genetics-based disorder and is a treatable but life-long condition. This report has presented the basic information regarding the appliance of medications within and beyond the terms of FDA regulations, but contemporary knowledge suggests that following FDA guidelines adequately limits the use of drugs. As for the financial perspective of ASD treatment, its persistence cannot be denied the as absence of sufficient funding and hence well-being adversely reflects on the entire family.
The paper has also placed the emphasis on the fact that grants do not suggest effective assistance while the density of affordable mental health institutions and special education schools leaves much to be desired. Still, the influence and participation of family in addressing autism spectrum disorders are essential as parents/family can provide the best care, education, correction, observation, and even interventions for their disabled child.